Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
1.030
+0.020 (1.98%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Cardiac and Coronary Disease Products | 8.27M | 8.74M | 8.86M | 8.54M | 7.92M | | | | | |
Cardiac and Coronary Disease Products Growth | -5.38% | -1.40% | 3.76% | 7.85% | 6.45% | | | | | |
| 8.27M | 8.74M | 8.86M | 8.54M | 7.92M | | | | | |
| -5.38% | -1.40% | 3.76% | 7.85% | 6.45% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 8.27M | 8.74M | 8.86M | 8.54M | 7.92M | | | | | |
| -5.38% | -1.40% | 3.76% | 7.85% | 6.45% | | | | | |
| 8.27M | 8.74M | 8.86M | 8.54M | 7.92M | | | | | |
| -5.38% | -1.40% | 3.76% | 7.85% | 6.45% | | | | | |
Source: S&P Global Market Intelligence.